Biofrontera Ag (BFRA) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access BFRA Annual Income Statement →
This page allows investors to track Biofrontera Ag's income statement performance across multiple reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2018)
Q4 2018
0 0 0 (Dec 31 2017)
Revenues
Total Revenue23.64
Costs & Expenses
Cost of Goods and Services Sold4.99
Gross Profit18.65
Selling, Administration, Marketing14.52
Research and Development Expense4.96
Other Operating Expense / -Income0.00
Total operating costs including COS44.34
Operating income / -loss-20.70
Interest Expense1.81
Net Interest Expense / -Income1.81
Other loss / -income-0.92
Total costs & expenses45.22
Income & Taxes
Income / -loss before income taxes-21.58
Income taxes expenses / -benefit-11.64
Income after income taxes-9.94
Income / -loss from continuing operations-9.94
Net income / -loss-9.94
Income / -loss to shareholder-10.73
EBIT-19.77
EBITD-19.77
EBITDA-19.77
Earnings Per Share
Basic EPS (excl. extra items)-0.22
Basic Net EPS-0.22
Basic shares outstanding (Mill. of Units)47.90
Diluted Net EPS-0.22
Diluted average shares (Mill. of Units)47.90
4 historic quarters locked

Sign in to unlock the full Biofrontera Ag income statement history.

About BFRA Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.